Novosanis is a Belgian-based medical device company that specializes in improving the quality of diagnostic tests for infectious diseases and oncology. As a subsidiary of OraSure Technologies Inc, Novosanis aims to meet all regulatory and quality requirements with its ISO13485 certified products. With a core team of 20+ members based in Wijnegem, Belgium, Novosanis also has a global presence with team members spread across the EU, Asia, and North America.

At the heart of the company is the Colli-Pee® family of products, which allows volumetric and standardized collection of first-void urine. This innovative platform offers variants that capture various urine volumes for different application purposes. Colli-Pee® makes urine collection easy, comfortable, and more accurate than traditional urine cups.

Furthermore, first-void urine collection has been proven to enhance the detection of infectious diseases, including sexually transmitted infections and certain cancers. Novosanis has received numerous awards, including the IWT Innovation Award and the Henry Van de Velde Award in Design for Healthcare. They are recognized for their dedication to excellence and innovation in medical device development.

With a global customer base, Novosanis continues to make strides in improving diagnostic testing for infectious diseases and oncology